Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $20.21 Analyst target: $23.43 Upside: 15.93%
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.